Maravai LifeSciences (MRVI) Misses Q1 EPS by 6c

Maravai LifeSciences (NASDAQ: MRVI) reported Q1 EPS of ($0.09), $0.06 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $64.2 million versus the consensus estimate of $60.55 million.

For earnings history and earnings-related data on Maravai LifeSciences (MRVI) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT
• Freedom Broker Starts Unity Bancorp (UNTY) at Hold